Quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) analysis
Real-time PCR analyses of quantification of hepatitis B virus (HBV) DNA and HBV covalently closed circular (ccc) DNA were performed as previously described 1 .
Total RNA from cultured cells was isolated using RNeasy Mini Kit (Qiagen, Hilden, Germany), and viral RNA was isolated using the RNeasy Mini Kit and RNase-Free DNase Set (Qiagen). First-strand cDNA was synthesized from 1 µg of RNA sample using PrimescriptII reverse transcriptase (Takara Bio, Shiga, Japan) according to the manufacturer's instructions. The resultant first cDNA samples were normalized by the number of GAPDH copies quantified by TaqMan PCR. The mRNA expression levels for HBV-RNA 2 and interferon-stimulated genes (MxA, ISG15, and PKR) 3 were quantified using QuantiTect SYBR Green PCR Kit (Qiagen). The mRNA expression levels for other genes were quantified using a Universal Probe Library (Roche Diagnostics, Indianapolis, IN, USA). Real-time PCR was performed using a
StepOnePlus Real Time PCR system (Thermo Fisher Scientific). Primer sequences are listed in Supplementary Table 1 .
Quantification of HBs and HBe antigens (Ags)
The concentrations of HBsAg and HBeAg in culture supernatants were quantified by a Chemiluminescent immunoassay, Architect HBsAg reagent kit and Architect
HBeAg reagent kit (Abbott Japan, Tokyo, Japan), respectively, according to the manufacturer's instructions.
Immunostaining of cultured cells
Cultured cells were fixed with 4% paraformaldehyde/PBS or 50% acetone/50% methanol and permeabilized using 0.5% Triton X-100/PBS. After blocking with 10%
Blocking One (Nakalai, Tokyo, Japan)/PBS, cells were incubated in primary antibodies overnight at 4°C. The cells were washed with PBS three times and were incubated with diluted secondary antibodies for 2 hours at room temperature. Then, the cells were washed with PBS and their nuclei were stained with DAPI. For each analysis, addition of an appropriate immune serum was used as a negative control. The microscopic photographs were taken using a fluorescent microscope (BZ-X710, Keyence, Osaka, Japan) or confocal laser microscope (FV10i, Olympus, Tokyo, Japan). The primary and second antibodies are listed in Supplementary Table 2 .
Immunoblot analysis
The protocol for immunoblotting was previously described 4 . Briefly, tissue samples were homogenized in RIPA buffer (50 mM, pH 8.0, Tris-HCl, 150 mM NaCl, 0.1% NP-40, 1% sodium deoxycholate, 1% sodium dodecyl sulfate) containing a Halt proteinase and phosphatase inhibitor cocktail (Thermo Fisher Scientific). After sodium dodecyl sulfate/polyacrylamide gel electrophoresis of cell homogenates (20 µg protein) and transfer to PVDF membranes, blots were incubated with primary antibodies (Supplementary Table 2 ), followed by incubation with peroxidase-labeled secondary antibodies (GE Healthcare, Uppsala, Sweden) and visualization using the ECL Western
Blotting Analysis System (GE Healthcare).
Supplementary Table 1 
HBV, hepatitis B virus; NL, NanoLuc; MxA, myxovirus resistance gene A; PKR, protein kinase R; ISG15, interferon stimulated gene 15; 2-MG, 2-microglobulin; IFN, interferon; F, forward primer; R, reverse primer. 
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